Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHEmotherapy-induced Cardiotoxicity and Study of risK Factor Correlation in Patients With Colorectal Cancer Receiving Oral or INfusional Fluoropyrimidine Treatment - CHECKPOINT

NCT02665312 is registered in ClinicalTrials.gov with Fondazione del Piemonte per l'Oncologia as lead sponsor.

NCT NCT02665312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02665312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHEmotherapy-induced Cardiotoxicity and Study of risK Factor Correlation in Patients With Colorectal Cancer Receiving Oral or INfusional Fluoropyrimidine Treatment - CHECKPOINT
Lead sponsor
Fondazione del Piemonte per l'Oncologia
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2016
Completion date
January 31, 2019
Enrollment
200 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer